PE20030492A1 - Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales - Google Patents
Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginalesInfo
- Publication number
- PE20030492A1 PE20030492A1 PE2002001057A PE2002001057A PE20030492A1 PE 20030492 A1 PE20030492 A1 PE 20030492A1 PE 2002001057 A PE2002001057 A PE 2002001057A PE 2002001057 A PE2002001057 A PE 2002001057A PE 20030492 A1 PE20030492 A1 PE 20030492A1
- Authority
- PE
- Peru
- Prior art keywords
- treatment
- concentration
- prevention
- peroxide concentration
- peroxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA DE LIBERACION PROLONGADA QUE COMPRENDE UNA MEZCLA SINERGICA DE UNA FUENTE DE PEROXIDO EN UNA CANTIDAD DE 0,01mg A 500mg SELECCIONADO DE PEROXIDO DE CARBAMIDA Y UN BIOADHESIVO TAL COMO UN POLIMERO POLICARBOXILICO, QUE SE HINCHA EN EL AGUA Y QUE ES SOLUBLE EN LA MISMA SELECCIONADO DE POLICARBOFILO, CARACTERIZADA PORQUE SE MANTIENE UNA MUY BAJA CONCENTRACION DE PEROXIDO QUE SE LIBERA DURANTE UN PERIODO PROLONGADO DE AL MENOS 12 HORAS, EN UNA CANTIDAD SUFICIENTE PARA AUMENTAR LA CONCENTRACION DEL OXIGENO EN LA VAGINA, PROPORCIONANDO BENEFICIOS AL DISMINUIR EL pH DE LA VAGINA SIN ESTERILIZACION O SIN ELIMINACION DE LA FLORA VAGINAL LOCAL NORMALMENTE DESEADA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE INFECCIONES VAGINALES
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33068301P | 2001-10-29 | 2001-10-29 | |
US10/278,910 US7709026B2 (en) | 2001-10-29 | 2002-10-24 | Low concentration of peroxide for treating or preventing vaginal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030492A1 true PE20030492A1 (es) | 2003-06-16 |
Family
ID=26959335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002001057A PE20030492A1 (es) | 2001-10-29 | 2002-10-28 | Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales |
Country Status (31)
Country | Link |
---|---|
US (1) | US7709026B2 (es) |
EP (1) | EP1441769B1 (es) |
JP (2) | JP5153049B2 (es) |
KR (1) | KR101009146B1 (es) |
CN (1) | CN1578676A (es) |
AR (1) | AR037047A1 (es) |
AT (1) | ATE297222T1 (es) |
AU (1) | AU2002346897B2 (es) |
BR (1) | BR0213584A (es) |
CA (1) | CA2465133C (es) |
DE (1) | DE60204584T2 (es) |
DK (1) | DK1441769T3 (es) |
ES (1) | ES2243772T3 (es) |
HK (1) | HK1063290A1 (es) |
HR (1) | HRP20040480B1 (es) |
HU (1) | HU229487B1 (es) |
IL (2) | IL161512A0 (es) |
MA (1) | MA26289A1 (es) |
ME (1) | MEP34608A (es) |
MX (1) | MXPA04003977A (es) |
MY (1) | MY137791A (es) |
NO (1) | NO20042199L (es) |
NZ (1) | NZ532294A (es) |
PE (1) | PE20030492A1 (es) |
PL (2) | PL216746B1 (es) |
PT (1) | PT1441769E (es) |
RS (1) | RS51154B (es) |
RU (1) | RU2329829C2 (es) |
SI (1) | SI1441769T1 (es) |
WO (1) | WO2003037382A1 (es) |
ZA (1) | ZA200402943B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8425892B2 (en) * | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
CH697081A5 (de) * | 2002-01-22 | 2008-04-30 | Andreas F Dr Schaub | Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten. |
US20040126369A1 (en) * | 2002-12-30 | 2004-07-01 | Richard Payne | Delivery of peroxide-generating enzymes to the vaginal tract |
DE10328942A1 (de) * | 2003-06-27 | 2005-01-27 | Lts Lohmann Therapie-Systeme Ag | Transmukosale Darreichungsformen mit verminderter Schleimhautirritation |
ES2237298B1 (es) | 2003-07-16 | 2006-11-01 | Italfarmaco, S.A. | Formulaciones mucoadhesivas semisolidas. |
US20050276865A1 (en) * | 2004-05-20 | 2005-12-15 | Servet Buyuktimkin | Peroxide compounds for the prevention and treatment of sexual dysfunction in humans |
DE102004054552A1 (de) * | 2004-11-11 | 2006-05-18 | Hcb Happy Child Birth Holding Ag | Neue Zusammensetzung zur Erleichterung der Humangeburt |
ES2344673B1 (es) | 2008-08-07 | 2011-05-03 | Italfarmaco, S.A. | Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral. |
US10383894B2 (en) * | 2010-03-17 | 2019-08-20 | Lutran Industries, Inc. | Human medicinal treatment using salt of peroxymonosulfuric acid |
US20120074014A1 (en) * | 2010-09-27 | 2012-03-29 | Lutran Industries, Inc. | Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication |
GB201108879D0 (en) * | 2011-05-25 | 2011-07-06 | Isis Innovation | Vector |
US9895311B2 (en) | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
US20180280340A1 (en) * | 2017-03-30 | 2018-10-04 | Konstantin Zubovskiy | Method of treating and preventing infections |
KR20200009079A (ko) | 2017-05-23 | 2020-01-29 | 파르미바 아베 | 활성제를 체강에 전달하기 위한 포말-형성 조성물 |
WO2020084548A1 (en) * | 2018-10-26 | 2020-04-30 | Viramal Limited | Mucoadhesive gel composition |
US11850303B2 (en) * | 2020-10-27 | 2023-12-26 | Uqora, Inc. | Gel and a suppository and methods to provide the gel and suppository |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798053A (en) * | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
BE535125A (es) * | 1954-01-25 | |||
NL108604C (es) * | 1957-08-27 | |||
US4127515A (en) * | 1974-10-21 | 1978-11-28 | Colgate-Palmolive Company | Waxing sponge |
US4607101A (en) * | 1981-08-27 | 1986-08-19 | Jaye-Boern Laboratories, Inc. | Method of treating acne vulgaris with a composition containing carbamide peroxide |
US4615697A (en) * | 1983-11-14 | 1986-10-07 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
US4657935A (en) * | 1985-07-22 | 1987-04-14 | Carlos Teplicki | Real acne control (RAC) |
US4923677A (en) * | 1985-08-07 | 1990-05-08 | Roy T. Witkin | Chemical sterilization |
US4997625A (en) * | 1985-08-07 | 1991-03-05 | Simon Gilbert I | Chemical sterilization |
US4670256A (en) * | 1985-09-23 | 1987-06-02 | V. Valhalla Corp. | Vaginal conditioning for sexual activity |
US4781923A (en) * | 1987-07-20 | 1988-11-01 | Pellico Michael A | Antiseptic gels |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
US6017521A (en) * | 1989-10-31 | 2000-01-25 | Columbia Laboratories, Inc. | Use of polycarboxylic acid polymers to treat vaginal infections |
US5376006A (en) * | 1990-03-22 | 1994-12-27 | Ultradent Products, Inc. | Dental bleaching compositions and methods for bleaching teeth surfaces |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5573765A (en) * | 1991-02-19 | 1996-11-12 | Mark S. Reinhard | Composition and method for treatment of vaginal yeast infections |
US5340836A (en) * | 1991-02-19 | 1994-08-23 | Mark S. Reinhard | Composition and method for treatment of vaginal yeast infections |
IT1250421B (it) * | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5571533A (en) * | 1992-02-07 | 1996-11-05 | Recordati, S.A., Chemical And Pharmaceutical Company | Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide |
US5667817A (en) * | 1992-03-20 | 1997-09-16 | Alcide Corporation | Method and composition for prevention and treatment of female lower genital tract microbial infections |
US5898037A (en) * | 1992-11-13 | 1999-04-27 | Marx; Alvin J. | Formulations of magnesium compounds for local application and methods of treatment using the same |
US5330761A (en) * | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
US5489435A (en) * | 1993-07-06 | 1996-02-06 | Ratcliff; Perry A. | Composition for treatment of abnormal conditions of the epithelium of bodily orifices |
US6200557B1 (en) * | 1993-07-06 | 2001-03-13 | Perry A. Ratcliff | Method of treating HIV by a topical composition |
US5543150A (en) | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
UA39965C2 (uk) * | 1993-12-03 | 2001-07-16 | Лайфор Леборетріз Лтд | Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти ) |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5741525A (en) * | 1995-10-24 | 1998-04-21 | Marshall University Research Corporation | Vaginal pharmaceutical hydrogen peroxide composition |
AU713849B2 (en) * | 1995-12-27 | 1999-12-09 | Janssen Sciences Ireland Uc | Bioadhesive solid dosage form |
US5778886A (en) * | 1996-02-27 | 1998-07-14 | Shihata; Alfred | Vaginal compositions combining a spermicidal agent and a peroxygen compound |
US5819742A (en) * | 1996-11-06 | 1998-10-13 | Family Health International | Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both |
US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
US5843998A (en) * | 1997-06-30 | 1998-12-01 | Song; Jin | Skin blemish treatment |
DE69819748T2 (de) | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
US6248358B1 (en) | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
US6117859A (en) * | 1997-11-04 | 2000-09-12 | The Research Foundation Of State University Of New York | Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides |
CN1306444A (zh) | 1998-06-19 | 2001-08-01 | 奥西比奥公司 | 具有抗感染和避孕性能的医学装置 |
US6277363B1 (en) * | 1998-09-21 | 2001-08-21 | Vortech, Inc. | Method and composition for treating chlamydia infection |
US6159491A (en) * | 1999-02-12 | 2000-12-12 | Biovector Technologies, Inc. | Prolonged release bioadhesive vaginal gel dosage form |
CA2386422A1 (en) | 1999-10-22 | 2001-04-26 | Lif-Hlaup Ehf. Bio-Gels Pharmaceuticals Inc. | Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
US6200551B1 (en) * | 2000-01-27 | 2001-03-13 | Susan Ann Morgan | Treatment for dry mouth employing carbamide peroxide |
US6235314B1 (en) * | 2000-08-08 | 2001-05-22 | Sarfaraz K. Niazi | Analgesic, anti-inflammatory and skeletal muscle relaxant compositions |
AU2002211842A1 (en) * | 2000-10-02 | 2002-04-15 | The Research Foundation Of State University Of New York | Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
US20030211173A1 (en) | 2002-05-08 | 2003-11-13 | Veach Tom C. | Lubrication composition |
CA2534778C (en) * | 2003-08-06 | 2010-11-16 | The Procter & Gamble Company | Absorbant structures comprising coated water-swellable material |
US20090156672A1 (en) * | 2007-12-17 | 2009-06-18 | Northwestern University | Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities |
-
2002
- 2002-10-24 US US10/278,910 patent/US7709026B2/en not_active Expired - Lifetime
- 2002-10-28 AR ARP020104078A patent/AR037047A1/es not_active Application Discontinuation
- 2002-10-28 HU HU0401672A patent/HU229487B1/hu unknown
- 2002-10-28 IL IL16151202A patent/IL161512A0/xx unknown
- 2002-10-28 BR BR0213584-1A patent/BR0213584A/pt not_active Application Discontinuation
- 2002-10-28 RS YUP-366/04A patent/RS51154B/sr unknown
- 2002-10-28 PE PE2002001057A patent/PE20030492A1/es not_active Application Discontinuation
- 2002-10-28 RU RU2004116312/15A patent/RU2329829C2/ru not_active IP Right Cessation
- 2002-10-28 CN CNA028215664A patent/CN1578676A/zh active Pending
- 2002-10-28 CA CA2465133A patent/CA2465133C/en not_active Expired - Lifetime
- 2002-10-28 DE DE60204584T patent/DE60204584T2/de not_active Expired - Lifetime
- 2002-10-28 EP EP02783026A patent/EP1441769B1/en not_active Expired - Lifetime
- 2002-10-28 PT PT02783026T patent/PT1441769E/pt unknown
- 2002-10-28 MX MXPA04003977A patent/MXPA04003977A/es active IP Right Grant
- 2002-10-28 DK DK02783026T patent/DK1441769T3/da active
- 2002-10-28 PL PL369725A patent/PL216746B1/pl not_active IP Right Cessation
- 2002-10-28 MY MYPI20024019A patent/MY137791A/en unknown
- 2002-10-28 AT AT02783026T patent/ATE297222T1/de active
- 2002-10-28 ES ES02783026T patent/ES2243772T3/es not_active Expired - Lifetime
- 2002-10-28 WO PCT/EP2002/012043 patent/WO2003037382A1/en active IP Right Grant
- 2002-10-28 ME MEP-346/08A patent/MEP34608A/xx unknown
- 2002-10-28 PL PL402550A patent/PL402550A1/pl not_active Application Discontinuation
- 2002-10-28 AU AU2002346897A patent/AU2002346897B2/en not_active Ceased
- 2002-10-28 NZ NZ532294A patent/NZ532294A/en not_active IP Right Cessation
- 2002-10-28 SI SI200230172T patent/SI1441769T1/sl unknown
- 2002-10-28 JP JP2003539722A patent/JP5153049B2/ja not_active Expired - Fee Related
- 2002-10-28 KR KR1020047006272A patent/KR101009146B1/ko not_active IP Right Cessation
-
2004
- 2004-04-19 ZA ZA2004/02943A patent/ZA200402943B/en unknown
- 2004-04-19 IL IL161512A patent/IL161512A/en not_active IP Right Cessation
- 2004-04-29 MA MA27664A patent/MA26289A1/fr unknown
- 2004-05-26 NO NO20042199A patent/NO20042199L/no not_active Application Discontinuation
- 2004-05-27 HR HR20040480A patent/HRP20040480B1/xx not_active IP Right Cessation
- 2004-08-12 HK HK04106057A patent/HK1063290A1/xx not_active IP Right Cessation
-
2010
- 2010-07-02 JP JP2010152148A patent/JP2010248232A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20030492A1 (es) | Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales | |
Basrani et al. | Update on endodontic irrigating solutions | |
US5736582A (en) | Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment | |
US5958984A (en) | Method and composition for skin treatment | |
AR052399A1 (es) | Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos | |
PE20020102A1 (es) | Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales | |
ATE421248T1 (de) | Antiseptische zusammensetzungen und verfahren | |
ATE319427T1 (de) | Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr | |
CO6251259A2 (es) | Formulaciones farmaceuticas de estriol en baja dosis | |
TR200003074T2 (tr) | Poloksamerler ve başka mikrobisidler içeren formülasyon. | |
BR0212163A (pt) | Composição para tratamento ou prevenção de infecção em plantas | |
BR0113751A (pt) | Composições cosméticas e farmacêuticas e seus empregos | |
PL373276A1 (en) | Trans-epicutaneous administration form for treating restless leg syndrome | |
JP2005510505A5 (es) | ||
DE69227259T2 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
CN101642467B (zh) | 长效消毒膏 | |
US20110086108A1 (en) | Dissolving powders that can be mixed with water and used as an oral rinse | |
Dhamija et al. | A Review on Agents for Chemo-mechanical Caries Removal | |
ES2242439T3 (es) | Composicion para el tratamiento de quemaduras. | |
ES2147796T3 (es) | Composicion para el tratamiento o la prevencion del herpes. | |
ME00858B (me) | UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA | |
UA88446C2 (uk) | Препарат, що містить аскорбінову кислоту, для лікування та профілактики вагінальних грибкових інфекцій | |
ES2194983T3 (es) | Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio. | |
CO5580798A2 (es) | Composicion de peroxido de liberacion prolongada para infecciones vaginales | |
KR200391208Y1 (ko) | 순은사가 함유된 양말(덧버선) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |